Back to search
FDAFDA · Food and drugs·Recall number D-1029-2017

PHENYLephrine 200 mg in 0.9% Sodium Chloride 250 mL, Rx only, SCA Pharmaceuticals 8821 Knoedl Ct Little Rock, AR 72205 --- NDC# 70004-0815-40

Published August 2, 2017 · Recall initiated: July 14, 2017

Summary

FDA records drug Class II recall D-1029-2017, published August 2, 2017 and initiated July 14, 2017. Recalling firm: SCA Pharmaceuticals; Status: Terminated; Reported quantity: N/A; Lot: Lot: 20170511@51 BUD: 8/9/2017. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility; product has the potential to leak.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
SCA Pharmaceuticals
Distributor
Nationwide
Lot
Lot: 20170511@51 BUD: 8/9/2017
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was PHENYLephrine 200 mg in 0.9% Sodium Chloride 250 mL, Rx only, SCA Pharmaceuticals 8821 Knoedl Ct Little Rock, AR 72205 --- NDC# 70004-0815-40 recalled?

Yes. FDA published recall D-1029-2017 on August 2, 2017. Reported hazard: Lack of Assurance of Sterility; product has the potential to leak.

What should I do if I have this product?

Voluntary: Firm initiated · Letter